Global expansion Volition Veterinary Diagnostics is positioned as an affordable screening test with availability in more than 20 countries, suggesting opportunities to partner with veterinary networks, distributors, and clinics internationally to broaden adoption and drive cross-border sales.

Early cancer screening The Nu.Q Vet Cancer Test targets routine wellness checks for older dogs and at-risk younger dogs, presenting a clear up-sell path for clinics to add a preventive screening offering that can increase visit frequency and test utilization.

Veterinary partnerships Development in collaboration with Texas A&M University and dissemination at major veterinary oncology conferences indicate strong credibility; leverage academic partnerships and thought leadership to win clinic buy-in and veterinary network endorsements.

Affordability focus Emphasis on an affordable, easy-to-use ELISA screening positions the product as a cost-effective addition to standard care, enabling sales conversations centered on value-based pricing for clinics and pet owners.

Market education There is a market gap for routine cancer screening in veterinary care; target clinics with educational content and demos that highlight improved diagnostic pathways, faster decision-making, and enhanced owner satisfaction to drive adoption and referrals.